Formulation and Evaluation of Moxifloxacin Hydrochloride Niosomes for Controlled Ophthalmic Drug Delivery

dc.contributor.authorVarinder Kaur
dc.contributor.authorPravin Pawar
dc.date.accessioned2025-12-16T06:55:56Z
dc.date.available2025-12-16T06:55:56Z
dc.date.issued2015-05-20
dc.description.abstractThe objective of present invesigation was to formulate and evaluate a niosomal delivery system of moxifloxacin hydrchloride for the treatment of ocular infections. Moxifloxacin-loaded niosomes were prepared by using thin film hydration technique and were investigated for surface pH, morphology, entrapment, in-vitro release, TEeM (transmission electron microscopy), physical stability & ocular irritancy test. The release study profile was subjected to release kinetics models. Aall the vesicles were uniform and spherical in size. The drug relaese pattern of all formulation follows decreasing order: MN3 > MN6 > MN9 > MN5 > MN2 > MN1 > MN8 > MN4 > MN7. The formulation MN3 (span 60: cholesterol) molar ratio produce faster release of drug i.e. 77.98% after 12 hours, concluded less sustained action. The study concluded that the moxifloxacin loaded niosomes to be effective in sustaining the drug release leading to decreased side effects and increased patient compliance.
dc.identifier.issn2321-2217
dc.identifier.issn2321-2225
dc.identifier.otherhttps://doi.org/10.15415/jptrm.2015.31002
dc.identifier.urihttps://demodspace.chitkara.edu.in/handle/123456789/179
dc.language.isoen
dc.publisherChitkara University Publications
dc.subjectMoxifoxacin
dc.subjectNiosomes
dc.subjectFilm Hydration Technique
dc.subjectsustianed release
dc.titleFormulation and Evaluation of Moxifloxacin Hydrochloride Niosomes for Controlled Ophthalmic Drug Delivery
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JPTRM Volume 3 Issue 1 002.pdf
Size:
331.05 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: